Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Still River Systems, a provider of proton therapy solutions, has closed a private financing round of $33 million. The round was co-led by Venrock Associates and existing investor Caxton Health and Life Sciences, with participation by CHL Medical Partners.
Subscribe to our email newsletter
In conjunction with this financing, Anders Hove of Venrock Associates and Myles Greenberg of CHL Medical Partners will join Still River Systems’s board of directors.
Still River Systems said that the proceeds from this financing will accelerate the development of its Monarch250 Proton Therapy System.
Marc Buntaine, CEO of Still River Systems, said: “Completion of this financing illustrates the investment community’s confidence in Still River’s business model and our ability to execute on our plan. We are pleased with the continued participation of our existing investors and warmly welcome our new investor partners, Venrock Associates and CHL Medical Partners.”